Afluria FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved September 28, 2007)
Brand name: Afluria
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Seqirus
Treatment for: Influenza Prophylaxis
Afluria is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in persons 6 months of age and older.
Development timeline for Afluria
| Date | Article |
|---|---|
| Oct 23, 2018 | Approval Seqirus Receives FDA Approval of Afluria and Afluria Quadrivalent (Influenza Vaccine) for People Six Months of Age and Older in the U.S. |
| Sep 28, 2007 | Approval CSL Biotherapies Announces FDA Marketing Approval of Afluria |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
